As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...
Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.
Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...
About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.
At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...
Everyday Health on MSN
How weight loss pills have changed — and what that means for safety
Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s ...
Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...
This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...
New research finds many people regain the weight they lost within two years of stopping GLP-1 drugs. But doctors say it's ...
Professors Svetlana Mojsov and Carlos Kenig, among other eminent figures, were selected to win the 48th session of the prize.
Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results